Concurrent paclitaxel and thoracic irradiation for locally advanced esophageal cancer

Seminars in Radiation Oncology

Volumn 9, Issue 2 SUPPL. 1, 1999, Pages 43-52

  Blanke, C D ^a   Choy, H ^a   Teng, M ^a   Beauchamp, R D ^a   Leach, S ^a   Roberts, J ^a   Washington, K ^a   Johnson, D H ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DOCETAXEL; ETOPOSIDE; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; PACLITAXEL;

ADVANCED CANCER; ALOPECIA; BLOOD TOXICITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; ESOPHAGUS CANCER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MUCOSA INFLAMMATION; NEUROPATHY; NEUTROPENIA; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; TOBACCO;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; HUMANS; NEOADJUVANT THERAPY; PACLITAXEL; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY DOSAGE; SURVIVAL RATE;

EID: 0032901564     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)